SCM
VCYT icon

Soleus Capital Management’s Veracyte VCYT Stock Holding History

Soleus Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
25,000
-294,912
-92% -$12.4M 0.05% 87
2026
Q1 		$10.3M Buy
319,912
+309,912
+3,099% +$11.5M 0.42% 47
2025
Q4 		$421K Sell
10,000
-412,055
-98% -$16.6M 0.02% 88
2025
Q3 		$14.5M Sell
422,055
-293,384
-41% -$8.42M 0.73% 35
2025
Q2 		$19.3M Buy
+715,439
New +$20.7M 1.28% 26
2024
Q4 		– Sell
-54,303
Closed -$1.85M – 109
2024
Q3 		$1.85M Buy
+54,303
New +$1.53M 0.14% 80

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Soleus Capital Management's VCYT Position: Q2 2026 in Review

Soleus Capital Management reduced its Veracyte (VCYT) stake by 92% in Q2 2026, selling an estimated $12.4M and leaving 25,000 shares worth $1.47M. The position accounts for 0.05% of the portfolio, ranked #87.

Soleus Capital Management first reported a position in VCYT in Q3 2024 and has held it in 6 quarters since. The position peaked at $19.3M in Q2 2025. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Soleus Capital Management held 25,000 shares of Veracyte worth $1.47M as of Q2 2026.
  • Soleus Capital Management sold 294,912 Veracyte shares in Q2 2026, an estimated $12.4M.
  • Veracyte made up 0.05% of Soleus Capital Management's portfolio in Q2 2026, its #87 holding.
  • Soleus Capital Management first reported a position in Veracyte in Q3 2024 and has held it in 6 quarters since.
  • Soleus Capital Management's Veracyte position peaked at $19.3M in Q2 2025.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.